Skip to main content
. 2015 Aug 1;4(3):e27631. doi: 10.5812/cardiovascmed.27631v2

Table 3. Comparison of Predictors Between Groups of NYHA Function Class a,b.

Variables NYHA Function Class P Value
III (n = 11) II (n = 22)
PRL (ng/mL) 17.28 ± 7.6 15.34 ± 7.8 0.5
T3 (nmoL/L) 1.8 ± 0.4 1.8 ± 0.4 0.8
T4 (nmoL/L) 8.8 ± 2.4 8.2 ± 1.9 0.4
TSH (mU/mL) 2.9 ± 1.18 2.21 ± 1.4 0.1
Testosterone (pmoL/l) 4.5 ± 1.7 5.2 ± 2.6 0.4
GH (ng/mL) 1.5 ± 2.5 0.2 ± 0.3 0.02
IGF1 (ng/mL) 128 ± 29.1 126.8 ± 52.9 0.9
6MWT (m) 364.91 ± 132.6 471.5 ± 90.64 0.01
NT Pro-BNP (ng/dL) 2715.28 ± 2080.77 770.88 ± 900.78 0.01
hs-CRP (mg/dL) 8.66 ± 16.93 5.49 ± 14.25 0.5
LVEF (%) 18.86 ± 9.18 24.89 ± 3.58 0.01

a Abbreviations: 6MWT, six-minute walk test; GH, growth hormone; hs-CRP, high-sensitive C-reactive protein; IGF-1, insulin-like growth factor 1; NT Pro-BNP, N-terminal pro-brain natriuretic peptide; PRL, prolactin; T3, triiodothyronine; T4, thyroxine; TSH, thyroid stimulating hormone.

bData are presented as Mean ± SD.